Apogem Capital’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Apogem Capital’s Portfolio MORF Stock Details MORF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,473	Closed	-$259K	–	199
2021 Q4	$259K	Buy	5,473 +93	+2%	+$4.99K	0.17%	146
2021 Q3	$305K	Buy	5,380 +439	+9%	+$26.6K	0.19%	147
2021 Q2	$284K	Buy	+4,941	New	+$272K	0.18%	148

Other funds holding MORF

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Apogem Capital's MORF Position: Q1 2022 in Review

Apogem Capital sold out of Morphic Holding, Inc. Common Stock (MORF) in Q1 2022, closing a stake of 5,473 shares — an estimated $259K sold.

Apogem Capital first reported a position in MORF in Q2 2021 and held it in 3 quarters. The position peaked at $305K in Q3 2021. 103 funds tracked by Wall St. Rank hold MORF as of Q1 2022.

Apogem Capital reported no remaining Morphic Holding, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Apogem Capital sold 5,473 Morphic Holding, Inc. Common Stock shares in Q1 2022, an estimated $259K.
Apogem Capital first reported a position in Morphic Holding, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
Apogem Capital's Morphic Holding, Inc. Common Stock position peaked at $305K in Q3 2021.
103 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q1 2022.

Based on Apogem Capital's 13F filing for Q1 2022, filed 16 May 2022.